Fidelity Disruptive Medicine Fund (FMEDX) Forecast
See the Price Targets and Ratings of:
FMEDX Analyst Rating
Moderate Buy
68ConsensusRatings
48Buy19Hold1Sell
Based on the Wall Street analyst consensus for 68 of FMEDX’s holdings.
FMEDX Analyst Price Target
Average Price Target
$13.72▲(21.63% Upside)
Based on Wall Street analyst 12-month price targets for 68 of Fidelity Disruptive Medicine Fund’s holdings in the last 3 months. The average price target is $13.72 with a high forecast of $16.54 and a low forecast of $11.02. The average price target represents a 21.63% change from the last price of $11.28.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$16.54
Average$13.72
Low$11.02
Past 12 Months12 Month Forecast$10$11.75$13.5$15.25$17Feb2026May2026Aug2026Nov2026Nov2027
What is FMEDX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 68 of FMEDX’s holdings, Fidelity Disruptive Medicine Fund’s 12-month average price target is $13.72.
What is FMEDX’s upside potential, based on the analysts’ average price target?
FMEDX’s average price target of $13.72 represents a 21.63% upside from its last price of $11.28.
Is FMEDX a Buy, Sell or Hold?
Fidelity Disruptive Medicine Fund has a consensus rating of Moderate Buy, based on the analyst consensus for 68 of FMEDX’s holdings: 48 rated Buy, 19 rated Hold and 1 rated Sell.
What is Fidelity Disruptive Medicine Fund’s price target?
The average price target for Fidelity Disruptive Medicine Fund is $13.72, based on Wall Street analyst 12-month price targets for 68 of FMEDX’s holdings, issued in the past 3 months. The highest price target is $16.54 and the lowest is $11.02. The average price target represents a 21.63% increase from the last price of $11.28.
How can I buy shares of FMEDX?
You can buy shares of FMEDX through a brokerage account. Compare brokers on our Best Online Brokers page.